Solu-cortef and Viral haemorrhagic cystitis - a phase IV clinical study of FDA data


Viral haemorrhagic cystitis is reported only by a few people who take Solu-Cortef.

The phase IV clinical study analyzes which people take Solu-cortef and have Viral haemorrhagic cystitis. It is created by eHealthMe based on reports of 6,371 people who have side effects while taking Solu-cortef from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 24, 2022

6,371 people reported to have side effects when taking Solu-cortef.
Among them, 5 people (0.08%) have Viral haemorrhagic cystitis.

What is Solu-cortef?

Solu-cortef has active ingredients of hydrocortisone sodium succinate. eHealthMe is studying from 6,388 Solu-cortef users for its effectiveness, alternative drugs and more.

What is Viral haemorrhagic cystitis?

Viral haemorrhagic cystitis (lower urinary tract symptoms that include haematuria and irritative voiding symptoms) is found to be associated with 165 drugs and 113 conditions by eHealthMe.

Number of Solu-cortef and Viral haemorrhagic cystitis reports submitted per year:

Could Solu-cortef cause Viral haemorrhagic cystitis?

Time on Solu-cortef when people have Viral haemorrhagic cystitis *:

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Viral haemorrhagic cystitis when taking Solu-cortef *:

  • female: 60 %
  • male: 40 %

Age of people who have Viral haemorrhagic cystitis when taking Solu-cortef *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 100 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

Common drugs people take besides Solu-cortef *:

  1. Foscavir: 4 people, 80.00%
  2. Vfend: 3 people, 60.00%
  3. Prograf: 3 people, 60.00%
  4. Lasix: 3 people, 60.00%
  5. Sandimmune: 2 people, 40.00%
  6. Fungizone: 2 people, 40.00%
  7. Fludara: 2 people, 40.00%
  8. Diflucan: 2 people, 40.00%
  9. Busulfex: 2 people, 40.00%
  10. Bactrim Ds: 2 people, 40.00%

Common side effects people have besides Viral haemorrhagic cystitis *:

  1. Venous Occlusion (the blocking of venous return): 3 people, 60.00%
  2. Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 3 people, 60.00%
  3. Bacterial Infection: 3 people, 60.00%
  4. Cytomegalovirus Infection: 3 people, 60.00%
  5. Diarrhea: 3 people, 60.00%
  6. Epstein-Barr Virus Infection: 3 people, 60.00%
  7. Fungal Infection: 3 people, 60.00%
  8. Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 3 people, 60.00%
  9. Infection: 3 people, 60.00%
  10. Pleural Effusion (water on the lungs): 3 people, 60.00%

Common conditions people have *:

  1. Cytomegalovirus Infection: 4 people, 80.00%
  2. Oedema (fluid collection in tissue): 3 people, 60.00%
  3. Infection: 3 people, 60.00%
  4. Bone Marrow Conditioning Regimen: 3 people, 60.00%
  5. Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 3 people, 60.00%
  6. Pericardial Effusion (fluid around the heart): 2 people, 40.00%
  7. Aspergillosis (an infection caused by a fungus called aspergillus): 2 people, 40.00%
  8. Pain: 1 person, 20.00%

* Approximation only. Some reports may have incomplete information.

Do you take Solu-cortef and have Viral haemorrhagic cystitis?

Check whether Viral haemorrhagic cystitis is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Viral haemorrhagic cystitis and when was it recovered:

Expand to all the drugs that have ingredients of hydrocortisone sodium succinate:

Alternative drugs to, pros and cons of Solu-cortef:

Common Solu-cortef side effects:

Browse all side effects of Solu-cortef:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Viral haemorrhagic cystitis treatments and more:

COVID vaccines that are related to Viral haemorrhagic cystitis:

Common drugs associated with Viral haemorrhagic cystitis:

All the drugs that are associated with Viral haemorrhagic cystitis:

All the conditions that are associated with Viral haemorrhagic cystitis:

How the study uses the data?

The study uses data from the FDA. It is based on hydrocortisone sodium succinate (the active ingredients of Solu-cortef) and Solu-cortef (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: